KARACHI – Following the meeting of the Board of Directors, ICI Pakistan Limited (the Company) announced its ?nancial results for the year ended June 30, 2021.
Financial Highlights
- On a consolidated basis (including the results of the Company’s subsidiaries: ICI Pakistan PowerGen Limited and NutriCo Morinaga (Private) Limited) net turnover for the year under review was PKR 64,766 million, a 17% increase over the same period last year (SPLY).
- The consolidated operating result at PKR 8,045 million was 43% higher in comparison to the SPLY. The strong results were driven by exceptional performance across all businesses particularly the Polyester, Pharmaceuticals and Animal Health businesses.
- The consolidated Pro?t after Tax (PAT) for the year was PKR 5,229 million of which loss of PKR 341 million is attributable to non-controlling interests. This translates into PAT attributable to the owners of the Holding Company at PKR 5,569 million and an EPS of PKR 60.30, both higher by 114% as compared to the SPLY. These stellar results were driven by operational excellence across all businesses, lower ?nance costs due to lower interest rates and debt levels, and a exchange gain compared to exchange loss during the SPLY. The Company recognised PKR 527 million as a share of pro?t from its Associate – NutriCo Pakistan (Private) Limited.
- On a standalone basis, PAT and EPS for the year under review at PKR 5,959 million and PKR 64.52 per share respectively, are 92% higher than SPLY.
- Based on the results, the Company has announced a ?nal cash dividend of 200% i.e. PKR 20/share. This is in addition to 200% interim cash dividend (i.e. PKR 20/share) already paid, making a total cash dividend of 400% (i.e. PKR 40/share) for the year ended June 30, 2021.
Following the announcement of results for the year, ICI Pakistan Limited Chief Executive Mr. Asif Jooma said, ‘ICI Pakistan has delivered stellar results for the year which is marked by growth and exceptional performance across all businesses. Guided by its core values of customer centricity and passion for people, the Company remained steadfast despite the challenges posed by COVID-19 – delivering enduring value to all of its stakeholders.’
